Literature DB >> 23157995

Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.

Milton G Roxanas1, Glenn E Hunt.   

Abstract

BACKGROUND: Glucocorticoids are widely used in medicine and are known to cause psychiatric side effects, including mania. There is anecdotal evidence that sodium valproate is effective for treating psychiatric side effects of glucocorticoids.
OBJECTIVE: To describe a case series of 20 patients receiving corticosteroids for various medical conditions who developed manic-like symptoms. They were treated with sodium valproate while continuing on corticosteroids.
METHOD: Patients treated with corticosteroids who reported to their physician subjective distress or who were openly disruptive in the ward were assessed by a consultation-liaison psychiatrist on the same day with the Young Mania Rating Scale. Immediately afterwards, blood was taken to measure the cortisol or dexamethasone level and then started on sodium valproate 500 mg twice daily. Valproate levels were measured on day 3 to adjust the dose.
RESULTS: There was a significant, rapid improvement of symptoms within 48 hours after sodium valproate was initiated. Within 72 hours all patients were euthymic and remained so over the ensuing week. The only major side effect was hyperammonemia in 1 case which resolved when valproate was stopped.
CONCLUSIONS: This case series shows that sodium valproate is a safe medication that rapidly reverses manic-like symptoms within a few days without needing to stop the corticosteroids, thus allowing the medical treatment to continue. The ability to continue treatment while controlling or ameliorating the psychiatric side effects of glucocorticoids with sodium valproate is an advance over previous approaches. The mechanism of this rapid action is unclear and deserves further study. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157995     DOI: 10.1016/j.psym.2012.06.006

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

Review 1.  Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with Glucocorticoids.

Authors:  Ciro Manzo; Jordi Serra-Mestres; Alberto Castagna; Marco Isetta
Journal:  Medicines (Basel)       Date:  2018-08-01

2.  Acute-onset Mania in a Patient with Non-small Cell Lung Cancer.

Authors:  Kate N Warren; Jhansi Katakam; Eduardo D Espiridion
Journal:  Cureus       Date:  2019-08-20

3.  Relapse in bipolar disorder in hospitalized patients with COVID-19: A case series and key recommendations.

Authors:  Tushar Kanta Panda; Naresh Nebhinani; Navratan Suthar; Swati Choudhary; Kartik Singhai
Journal:  Indian J Psychiatry       Date:  2021-12-03       Impact factor: 1.759

Review 4.  Glucocorticoids-Induced Neuropsychiatric Disorders in Patients With Inflammatory Bowel Disease: A Systematic Review.

Authors:  Safina Ali; Salomi Paul; Shreyas Yakkali; Sneha Teresa Selvin; Sonu Thomas; Viktoriya Bikeyeva; Ahmed Abdullah; Aleksandra Radivojevic; Anas A Abu Jad; Anvesh Ravanavena; Chetna Ravindra; Emmanuelar O Igweonu-Nwakile; Pousette Hamid
Journal:  Cureus       Date:  2022-09-09

5.  Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder.

Authors:  C L Clelland; V Drouet; K C Rilett; J A Smeed; R H Nadrich; A Rajparia; L L Read; J D Clelland
Journal:  Transl Psychiatry       Date:  2016-09-13       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.